For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260127:nRSa4423Qa&default-theme=true
RNS Number : 4423Q Zotefoams PLC 27 January 2026
Zotefoams plc
(the 'Company')
Change of Registered Office Address
27 January 2026
Zotefoams plc (the "Company") announces that, following approval by the Board
on 21 January 2026, the Company has filed the necessary documentation with
Companies House to update its registered office address.
The Company's registered office has now changed to:
Salisbury House, Finsbury Circus, London, England, EC2M 7AQ
This change is effective immediately and has been reflected on the public
register.
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in supercritical fluid foam
technology, delivering optimal material solutions for the benefit of society.
Utilising a variety of unique manufacturing processes, including
environmentally friendly nitrogen expansion for lightweight AZOTE® and
ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide
across three market verticals, Consumer & Lifestyle, Transport & Smart
Technologies, and Construction & Other Industrial. Zotefoams uses its own
materials to manufacture T-FIT® advanced insulation for demanding industrial
markets.
Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites
in Kentucky, USA and Brzeg, Poland (foam manufacture), and foam products
conversion in Oklahoma, USA and Jiangsu Province, China (T-FIT).
www.zotefoams.com
AZOTE®, ZOTEK® and T-FIT® are registered trademarks of Zotefoams plc.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END CROPPUQCGUPQPUQ
Copyright 2019 Regulatory News Service, all rights reserved